Related by context. Frequent words. (Click for all words.) 74 Phase III randomized 74 multicenter randomized 74 Phase Ib clinical 73 placebo controlled clinical 72 Multicenter 72 multicentre 71 prospective randomized controlled 71 randomized Phase III 70 randomized controlled clinical 70 blind randomized controlled 70 placebo controlled randomized 70 multicenter clinical 70 multicenter randomized double 69 prospective randomized 69 multicenter 68 randomized clinical 68 substudy 68 randomized placebo controlled 68 phase IIa 67 Phase 1b clinical 67 Randomized 67 prospective observational 67 randomized controlled 66 Thrombolysis 66 Acute Myocardial Infarction 66 double blinded placebo 66 PRECiSE 65 phase IIb 65 Gynecologic Oncology Group 65 SPIRIT III 65 NSABP 65 blinded placebo controlled 65 dose escalation trial 65 label multicenter 65 randomized 65 PRECISE 65 Pivotal Phase III 64 TRITON TIMI 64 neoadjuvant 64 blind randomized 64 Pivotal Trial 64 Phase Ia 64 Phase 2a clinical 64 placebo controlled 64 Carotid 63 nab paclitaxel 63 multicenter study 63 subgroup analyzes 63 RADIANT 63 noninferiority 63 Pivotal Phase 63 SWOG 63 pertuzumab 62 pharmacodynamic effects 62 Phase Ib 62 Phase IIa clinical 62 randomized double 62 irbesartan 62 Phase 1a 62 RTOG 62 blind randomized placebo 62 EORTC 62 RRMS patients 62 axitinib 62 randomized controlled trial 62 Phase 2b clinical 62 retrospective cohort study 61 mycophenolate mofetil 61 active comparator 61 ATTRACT 61 phase 2a 61 Pharmacokinetic 61 randomized #:# 61 Phase 2b study 61 Myocardial Infarction 61 Amrubicin 61 chemoradiotherapy 61 double blind placebo 61 Phase 1b 61 liver transplant recipients 61 RIBBON 61 Cloretazine R VNP#M 61 evaluable patients 61 dose escalation study 61 Phase IIa trial 61 placebo controlled studies 60 SYNTAX 60 metastatic hormone refractory 60 randomized controlled clinical trials 60 carotid artery stenting 60 Phase III Clinical Trial 60 Phase IIb clinical 60 plus prednisone 60 Phase III pivotal 60 MIRCERA 60 randomized Phase 60 Phase 1b trial 60 Phase 2b trial 60 relapsed refractory multiple myeloma 59 Phase 2a trial 59 metastatic renal cell carcinoma